Experts are excitedly investigating retatrutide, a innovative treatment created by Eli Lilly, as a potential advance in weight management. Unlike many existing approaches, retatrutide is a double -action agonist targeting equally GLP-1 and GIP, substances that impact satiety and blood sugar cont… Read More